Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

Novel diagnostic biomarkers of prostate cancer: an update.

Anceschi U, Tuderti G, Lugnani F, Biava PM, Malossini G, Luciani L, Cai T, Marsiliani D, Filianoti A, Mattevi D, Costantini M, Misuraca L, Simone G.

Curr Med Chem. 2018 Sep 13. doi: 10.2174/0929867325666180914115416. [Epub ahead of print]

PMID:
30215331
2.

Tissue Regeneration without Stem Cell Transplantation: Self-Healing Potential from Ancestral Chemistry and Physical Energies.

Facchin F, Bianconi E, Canaider S, Basoli V, Biava PM, Ventura C.

Stem Cells Int. 2018 Jul 3;2018:7412035. doi: 10.1155/2018/7412035. eCollection 2018. Review.

3.

Stem Cell Differentiation Stage Factors and Their Role in Triggering Symmetry Breaking Processes during Cancer Development: A Quantum Field Theory Model for Reprogramming Cancer Cells to Healthy Phenotypes.

Biava PM, Burigana F, Germano R, Kurian P, Verzegnassi C, Vitiello G.

Curr Med Chem. 2017 Sep 20. doi: 10.2174/0929867324666170920142609. [Epub ahead of print]

PMID:
28933288
4.

Immunotherapy and Hormone-therapy in Metastatic Breast Cancer: A Review and an Update.

Nicolini A, Carpi A, Ferrari P, Biava PM, Rossi G.

Curr Drug Targets. 2016;17(10):1127-39. Review.

PMID:
26844558
5.

Cancer: A Problem of Developmental Biology; Scientific Evidence for Reprogramming and Differentiation Therapy.

Sell S, Nicolini A, Ferrari P, Biava PM.

Curr Drug Targets. 2016;17(10):1103-10. Review.

PMID:
26343109
6.

The PI3K-AKt-mTOR Pathway and New Tools to Prevent Acquired Hormone Resistance in Breast Cancer.

Nicolini A, Ferrari P, Kotlarova L, Rossi G, Biava PM.

Curr Pharm Biotechnol. 2015;16(9):804-15. Review.

PMID:
26201609
8.

Stem Cell Differentiation Stage Factors from Zebrafish Embryo: A Novel Strategy to Modulate the Fate of Normal and Pathological Human (Stem) Cells.

Biava PM, Canaider S, Facchin F, Bianconi E, Ljungberg L, Rotilio D, Burigana F, Ventura C.

Curr Pharm Biotechnol. 2015;16(9):782-92. Review.

9.

Complex Therapeutical Approaches to Complex Diseases.

Biava PM.

Curr Pharm Biotechnol. 2015;16(9):758. No abstract available.

PMID:
26201605
10.

Endocrine related cancer: from stem cells to new drug targets.

Nicolini A, Biava PM.

Curr Med Chem. 2014;21(9):1071. No abstract available.

PMID:
24304281
11.

Changing the endocrine dependence of breast cancer: data and hypotheses.

Nicolini A, Ferrari P, Biava PM, Carpi A.

Curr Med Chem. 2014;21(9):1093-106. Review.

PMID:
24304277
12.

A systemic approach to cancer treatment: tumor cell reprogramming focused on endocrine-related cancers.

Biava PM, Nicolini A, Ferrari P, Carpi A, Sell S.

Curr Med Chem. 2014;21(9):1072-81. Review.

PMID:
24304275
14.

The zebrafish embryo derivative affects cell viability of epidermal cells: a possible role in the treatment of psoriasis.

Norata GD, Biava PM, Di Pierro F.

G Ital Dermatol Venereol. 2013 Oct;148(5):479-83.

PMID:
24005140
15.

Reprogramming of normal and cancer stem cells.

Biava PM.

Curr Pharm Biotechnol. 2011 Feb 1;12(2):145. No abstract available.

PMID:
21303333
16.

Cancer cell reprogramming: stem cell differentiation stage factors and an agent based model to optimize cancer treatment.

Biava PM, Basevi M, Biggiero L, Borgonovo A, Borgonovo E, Burigana F.

Curr Pharm Biotechnol. 2011 Feb 1;12(2):231-42. Review.

PMID:
21044002
17.

Embryonic morphogenetic field induces phenotypic reversion in cancer cells. Review article.

Bizzarri M, Cucina A, Biava PM, Proietti S, D'Anselmi F, Dinicola S, Pasqualato A, Lisi E.

Curr Pharm Biotechnol. 2011 Feb 1;12(2):243-53. Review.

PMID:
21044001
18.

Zebrafish stem cell differentiation stage factors suppress Bcl-xL release and enhance 5-Fu-mediated apoptosis in colon cancer cells.

D'Anselmi F, Cucina A, Biava PM, Proietti S, Coluccia P, Frati L, Bizzarri M.

Curr Pharm Biotechnol. 2011 Feb 1;12(2):261-7.

PMID:
21043999
19.

Zebrafish embryo proteins induce apoptosis in human colon cancer cells (Caco2).

Cucina A, Biava PM, D'Anselmi F, Coluccia P, Conti F, di Clemente R, Miccheli A, Frati L, Gulino A, Bizzarri M.

Apoptosis. 2006 Sep;11(9):1617-28.

PMID:
16820966
20.

Treatment with stem cell differentiation stage factors of intermediate-advanced hepatocellular carcinoma: an open randomized clinical trial.

Livraghi T, Meloni F, Frosi A, Lazzaroni S, Bizzarri TM, Frati L, Biava PM.

Oncol Res. 2005;15(7-8):399-408.

PMID:
16491958

Supplemental Content

Loading ...
Support Center